Chief Executive Officer
ABSCINT
The startup develops in vivo diagnostics using single-domain antibodies for molecular imaging, focusing on immunology, oncology, and cardiology. Their technology enables precise disease diagnosis, treatment selection, and monitoring of treatment response based on specific molecular markers, improving patient outcomes in oncology and cardiovascular care.
- Biotechnology
- Healthcare Technology
Updated 23 months ago
Funding
Raised to date
$4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops in vivo diagnostics using single-domain antibodies for molecular imaging, focusing on immunology, oncology, and cardiology. Their technology enables precise disease diagnosis, treatment selection, and monitoring of treatment response based on specific molecular markers, improving patient outcomes in oncology and cardiovascular care.